Gastroparesis Worsens Indomethacin-Induced Gastric Antral Ulcers by Bile Reflux via Activation of 5-HT3 and Dopamine D2 Receptors in Mice

被引:2
|
作者
Satoh, Hiroshi [1 ]
Akiba, Yasutada [2 ,3 ]
Urushidani, Tetsuro [1 ]
Kaunitz, Jonathan D. [2 ,3 ]
机构
[1] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Dept Biopharmaceut, Kyotanabe, Kyoto 6100395, Japan
[2] Greater Los Angeles Vet Affairs Healthcare Syst, B114,R217,11301 Wilshire Blvd, Los Angeles, CA 90073 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90025 USA
关键词
Atropine; Bile reflux; Gastric antral ulcer; Gastroparesis; NSAIDs; DUODENOGASTRIC REFLUX; MOSAPRIDE CITRATE; INDUCED EMESIS; MOTILITY; PATHOGENESIS; LANSOPRAZOLE; ONDANSETRON; RANITIDINE; THERAPY; STOMACH;
D O I
10.1007/s10620-023-08086-x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims We examined the contributions of gastric emptying and duodenogastric bile reflux in the formation of gastric antral ulcers induced by NSAIDs in mice. Methods We used the murine re-fed indomethacin (IND) experimental ulcer model. Outcome measures included the appearance of gastric lesions 24 h after IND treatment and the assessment of gastric contents and the concentration of bile acids 1.5 h after re-feeding. The effects of atropine, dopamine, SR57227 (5-HT3 receptor agonist), apomorphine, ondansetron, haloperidol, and dietary taurocholate and cholestyramine were also examined. Results IND (10 mg/kg, s.c.) induced severe lesions only in the gastric antrum in the re-fed model. The antral lesion index and the amount of food intake during the 2-h refeeding period were positively correlated. Atropine and dopamine delayed gastric emptying, increased bile reflux, and worsened IND-induced antral lesions. SR57227 and apomorphine worsened antral lesions with increased bile reflux. These effects were prevented by the anti-emetic drugs ondansetron and haloperidol, respectively. The anti-emetic drugs markedly decreased the severity of antral lesions and the increase of bile reflux induced by atropine or dopamine without affecting delayed gastric emptying. Antral lesions induced by IND were increased by dietary taurocholate but decreased by the addition of the bile acid sequestrant cholestyramine. Conclusions These results suggest that gastroparesis induced by atropine or dopamine worsens NSAID-induced gastric antral ulcers by increasing duodenogastric bile reflux via activation of 5-HT3 and dopamine D-2 receptors.
引用
收藏
页码:3886 / 3901
页数:16
相关论文
共 5 条
  • [1] Gastroparesis Worsens Indomethacin-Induced Gastric Antral Ulcers by Bile Reflux via Activation of 5-HT3 and Dopamine D2 Receptors in Mice
    Hiroshi Satoh
    Yasutada Akiba
    Tetsuro Urushidani
    Jonathan D. Kaunitz
    Digestive Diseases and Sciences, 2023, 68 : 3886 - 3901
  • [2] Cholecystokinin-Induced Duodenogastric Bile Reflux Increases the Severity of Indomethacin-Induced Gastric Antral Ulcers in Re-fed Mice
    Satoh, Hiroshi
    Akiba, Yasutada
    Urushidani, Tetsuro
    Kaunitz, Jonathan D.
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (04) : 1156 - 1168
  • [3] Cholecystokinin-Induced Duodenogastric Bile Reflux Increases the Severity of Indomethacin-Induced Gastric Antral Ulcers in Re-fed Mice
    Hiroshi Satoh
    Yasutada Akiba
    Tetsuro Urushidani
    Jonathan D. Kaunitz
    Digestive Diseases and Sciences, 2024, 69 : 1156 - 1168
  • [4] Dual role of serotonin in the pathogenesis of indomethacin-induced small intestinal ulceration: Pro-ulcerogenic action via 5-HT3 receptors and anti-ulcerogenic action via 5-HT4 receptors
    Kato, Shinichi
    Matsuda, Narumi
    Matsumoto, Kenjiro
    Wada, Mai
    Onimaru, Naoki
    Yasuda, Masashi
    Amagase, Kikuko
    Horie, Syunji
    Takeuchi, Koji
    PHARMACOLOGICAL RESEARCH, 2012, 66 (03) : 226 - 234
  • [5] LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats
    Calik, Ilknur
    Yayla, Muhammed
    Cinar, Irfan
    Cadirci, Elif
    Albayrak, Abdulmecit
    Sirin, Busra
    Calik, Muhammet
    Halici, Zekai
    INFLAMMOPHARMACOLOGY, 2020, 28 (04) : 893 - 902